Category Covid-19

PIER MARIA FORNASARI
2022-01-18

SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing published by UK Health Security Agency

This report has been published to share the detailed variant surveillance analyses which contribute to the variant risk assessments and designation of new variants of concern (VOC) and variants under investigation (VUI). This specialist technical briefing contains early data and analysis on emerging variants and findings have a high level of uncertainty. SARS-CoV-2 Routine variant

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-18

Association between vaccination status and reported incidence of post-acute long-COVID-19 symptoms in Israel: double dose Pfizer-BioNTech vaccination may have a protective effect.

An emerging and complex health problem that remains poorly characterized and understood is long coronavirus disease 2019 (Long COVID). The rapid outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic. Long COVID is a post-infection condition in which individuals do not recover completely for

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-16

Viral dynamics and duration of PCR positivity of the SARSCoV-2 Omicron variant: a study of Harvard University researchers on NBA players

A significant proportion of people infected with the omicron variant of coronavirus were still contagious when they reach the U.S. Centers for Disease Control’s recommended self-isolation exit date of five days, according to a  Harvard University study of a small number of cases from the National Basketball Association’s Covid-19 testing program. KEY FACTS Among omicron cases identified 

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-15

COVID-19 nonhospitalized patients: therapeutic options review in Omicron era

Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint summarizes currently available therapeutics for nonhospitalized patients in the setting of the Omicron variant including principles for equitable allocation. Patients with mild or moderate COVID-19 are those who have respiratory and systemic

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-11

NEJM paper, compendium on rapid tests for COVID-19 published by University of Washington researcher

The FDA has approved 28 of the more than 1,000 such diagnostics commercially available worldwide. In brief: A clinical practice article in the New England Journal of Medicine distills available data and clinical experience into a compendium about rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The appendix identified nearly all FDA-approved rapid diagnostic tests and

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-11

A Japan National Institute of Infectious Diseases Control and Prevention Center study shows that Peak Infectiousness Of Omicron variant is 3-6 Days After Symptom Onset.

A new study conducted by Japanese researchers has shown that peak viral loads in people infected with omicron occur between 3 to 6 days after the onset of symptoms. The study raises further concerns about the CDC cutting the self-isolating time for people with Covid-19 to 5 days, not 10. The report was published online on January

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-06

National Strategy for the new normal life with Covid-19: three papers published on JAMA

Today, a group of eminent physicians and scientists with global standing have acted decisively and in unison presenting the world with what it badly needs, whether it knows it or not: a comprehensive, cohesive plan which lays out the steps to reverse the course of Covid-19. Presented today as three linked “Viewpoints” in one of the world’s

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2022-01-06

Predicting the future of COVID: Boston College biologists develop a computational model to detect emerging Coronavirus strains

Efforts to contain the spread of SARS-CoV-2 may benefit from a new analytical tool developed by a team led by biologists at Boston College, who report their computer simulation of molecular interactions can predict mutations of the virus and help develop insights into future variants of concern before they emerge. “We computationally predict what mutations

Read More

No Comments InCovid-19